About the company:
ZytoService is a leading pharmaceutical company that produces parenteral infusion solutions which are customised to individual patients’ needs. These solutions are primarily used in oncological treatment. The company operates state-of-the-art cleanroom laboratories at its principal site in Hamburg, where it focuses on the preparation of pharmaceutical products, tailored to individual patients. capiton invested in the company in August 2008 during a round of growth financing. The company has enjoyed significant growth in recent years, both organically and through acquisitions. Sales have more than quadrupled during the period of capiton’s investment.
About the transaction:
As part of this transaction, which has now been signed and which is still subject to regulatory approvals, capiton is selling its shares in Zyto Service to IK Investment Partners. The parties to the transaction have agreed not to disclose financial details of the transaction. capiton was advised by Ferber (M&A), Clifford Chance (Legal) and Deloitte (Financial) with respect to this transaction.